MS vs OGEN · P/E 20, $344.27B cap vs rev $37.7K
Morgan Stanley (MS) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
MS does not have a complete income-statement cache yet.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
MS currently screens at market cap $344.27B and trailing P/E 19.8. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the MS and OGEN stock pages for the full models.
Not investment advice.